Guardant Health Stock
Bio-tech company focus on oncology
Sign up today and learn more about Guardant Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Guardant Health Stock
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.
Anduril Industries, Sila Nanotechnologies, Cityblock Health, Blend, Aspiration, project44, Addepar, Illumio, BlueVoyant, Guardant Health
Wish, Scopely, Opendoor, Dollar Shave Club, Gusto, Coalition, Zipline, Plaid, Crusoe Energy Systems, Guild Education
Wish, Oscar Health, Virgin Hyperloop One, Collective Health, Blend, Illumio, Guardant Health, Bolt Threads, Aviatrix, Ironclad
Instacart, Stripe, DoorDash, Impossible Foods, Palantir Technologies, View, Zenefits, Eat Just, Opendoor, Faire
Lightspeed Venture Partners
Snap, OYO, AppDynamics, TripActions, Faire, Affirm, Netskope, LivingSocial, Weee!, Blend
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Alibaba, SoFi, Ola, Compass, Snapdeal, Plenty, Guardant Health, BuzzFeed, Fitbit, Lemonade
PharmEasy, Tokopedia, Ola, Magic Leap, DoorDash, Impossible Foods, Wish, Snyk, AvidXchange, SambaNova Systems
T. Rowe Price
One97, Flipkart, WeWork, Cruise, Airbnb, Rivian, Magic Leap, Nuro, Caris Life Sciences, Vroom
Chief Executive Officer
Chief Financial Officer
Chief Legal Officer
Chief Medical Officer
COO & President
VP of Marketing
Head of Sales
VP of Bioinformatics
Vice President, Pharma Business Development
Fairfield Current - Nov, 6 2018Guardant Health (NASDAQ:GH) Coverage Initiated by Analysts at Bank of America
Nasdaq - Nov, 1 2018October's winners & losers: Growth IPOs still fly high
Nasdaq Place (press release) - Oct, 31 2018Guardant Health, Inc. (GH) moves -0.38% below SMA-50
TechCrunch - Oct, 28 2018These 14 startups — endorsed by the seed-stage investment firm Pear — just hit the fundraising trail
MarketWatch - Sep, 6 2018Cancer blood-testing company Guardant Health files for IPO
GenomeWeb - Jul, 31 2018Guardant Silent on TMB Plans as Study Adds Evidence for Immunotherapy Prediction in Blood
Forbes - Jul, 19 2018Liquid Biopsy Controversy Rages On
- Jul, 12 2018Guardant Health Appoints Leena Das-Young to Lead Efforts to Develop Liquid Biopsy Products for Early-Stage Cancer Applications
PR Newswire (press release) - May, 23 2018Guardant Health to Present 29 Abstracts at ASCO Advancing the Science of Liquid Biopsy Across Multiple Indications ...
PR Newswire (press release) - Apr, 26 2018Guardant Health Publishes Extensive Validation of Guardant360® Assay Comprising Largest-Published Blood-Tissue ...
Healthcare Trends - Apr, 7 2018Guardant Health Inc Market Analysis 2018 to 2025
PR Newswire (press release) - Mar, 19 2018Guardant Health Applauds Medicare For Final Decision Benefiting Advanced Cancer Patients
PR Newswire (press release) - Mar, 13 2018Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of Lung Cancer Trial
PR Newswire (press release) - Feb, 15 2018The Guardant360® Assay Receives Expedited Access Pathway Designation for Breakthrough Devices from FDA
Medgadget (blog) - Feb, 12 2018Liquid Biopsy Market Growing Rates of Cancer Coupled with ...
Incredible News 24 - Jan, 22 2018Global Liquid Biopsy Market Projections 2018- Guardant Health, RainDanceTechnologies and Biocartis
PR Newswire (press release) - Nov, 16 2017Guardant Health Expands Support for the Development of the GuardantOMNI™ Assay Through New Agreement with ...
PR Newswire (press release) - Nov, 6 2017Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer
Medgadget (blog) - Oct, 17 2017Liquid Biopsy Market Size Is Anticipated To Reach $5.96 Billion By ...
Healio - Oct, 5 2017Liquid biopsies predict response to immunotherapy
PR Newswire (press release) - Sep, 26 2017Guardant Health Receives Investigational Device Exemption Approval from the FDA to Support Merck KGaA ...
Financial Times - Sep, 24 2017DNA start-ups attract cash from venture funds
GenomeWeb - Jun, 22 2017Guardant Health Sues Foundation Medicine for False Advertising
GenomeWeb - Jun, 5 2017Guardant Health, Foundation Medicine to Participate in Cure-One N1 Registry
PR Newswire (press release) - Jun, 3 2017Cure-One™ Announces Partnership with Guardant Health
GenomeWeb - May, 24 2017New York Approves Guardant Health's Liquid Biopsy Test
PR Newswire (press release) - May, 18 2017Guardant Health Announces Draft Medicare Local Coverage Determination for the Guardant360 Assay
News-Medical.net - May, 15 2017Guardant Health introduces new initiative to sequence tumor DNA of one million cancer patients
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase